IP Library Granted Patent US 10,028,854
Granted Patent B2
US 10,028,854 · App. 13/364,772 · Granted Jul 24, 2018

Stent retaining systems

Inventors: Joe Tatalovich (St. Louis Park, MN); Sara Thorson (Ann Arbor, MI); Megan Miezwa (Maple Grove, MN); Steve Zaver (Plymouth, MN); Rich Kusleika (Eden Prairie, MN); Paul Noffke (St. Paul, MN)
Assignee: Covidien LP
A61F2/962A61F2/915A61F2002/9505A61F2002/9511A61F2002/9517A61F2002/9665
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,854
App. No.
13/364,772
Filed
Feb 2, 2012
Granted
Jul 24, 2018
Kind
B2
Art Unit
3731
USPC
623/1.12
Abstract

A stent delivery system includes an expandable stent, a catheter, and a sheath. The expandable stent includes proximal and distal ends, and a first interlock structure. The catheter includes an elongated member having a second interlock structure displaceably arranged about an outer surface thereof for engaging the first interlock structure of the stent. The sheath is mounted on the elongated member and is positionable in a transport position in which the sheath covers the stent mounted on the elongated member and a deploy position in which the stent is exposed.

Claims (24)

1. A stent delivery system comprising:

an expandable stent having proximal and distal ends, and a first interlock structure;

an elongated inner member defining a longitudinal axis;

a floating retaining ring disposed on the inner member and having a second interlock structure for engaging the first interlock structure of the stent, the floating retaining ring adapted for longitudinal movement relative to the inner member, the floating retaining ring being discontinuous and defining free ends extending along an entire length of the floating retaining ring; and

a sheath mounted on the inner member, the sheath being positionable in a transport position in which the sheath covers the stent and a deployed position in which the stent is at least partially exposed.

2. The stent delivery system of claim 1 , wherein the floating ring is freely moveable along a longitudinal length of the inner member.

3. The stent delivery system of claim 1 , wherein the floating ring is moveable over a predetermined longitudinal length of the inner member.

4. The stent delivery system of claim 1 , wherein the expandable stent is a self-expanding stent.

5. The stent delivery system of claim 1 , wherein the free ends of the floating retaining ring define a gap therebetween.

6. The stent delivery system of claim 1 , wherein the free ends of the floating retaining ring at least partially overlap.

7. The stent delivery system of claim 1 , wherein the floating retaining ring includes separate ring sectors.

8. A stent delivery system, which comprises:

an elongated inner member defining a longitudinal axis, and having proximal and distal ends;

an expandable stent mounted adjacent the distal end of the inner member;

a generally annular retainer mounted to the inner member and dimensioned to releasably couple with the expandable stent, the retainer dimensioned for longitudinal movement along the inner member, the retainer defining a discontinuous ring having free ends extending an entire longitudinal length of the annular retainer; and

a sheath mounted on the inner member, the sheath being movable from a transport position covering the stent to a deployed position in which the stent is at least partially exposed.

9. The stent delivery system of claim 8 wherein the retainer and the stent include cooperating interlocking elements dimensioned to releasably couple the stent to the retainer.

10. The stent delivery system of claim 8 wherein the stent is self-expanding, whereby upon movement of the sheath to the deployed position the stent expands causing release of the stent from the retainer.

11. The stent delivery system of claim 8 , wherein the free ends of the discontinuous ring define a gap therebetween.

12. The stent delivery system of claim 8 , wherein the free ends of the discontinuous ring at least partially overlap.

13. The stent delivery system of claim 8 , wherein the discontinuous ring includes separate ring sectors.

14. The stent delivery system of claim 1 , wherein the second interlock structure is attached to an intermediate tube disposed between the elongated member of the catheter and the sheath.

15. The stent delivery system of claim 1 , wherein the second interlock structure is attached to the elongated member by a flexible structure that allows the second interlock structure to move a predetermined distance along the elongated member.

16. The stent delivery system of claim 15 , wherein the flexible structure is a spring.

Assignments (2)
CHANGE OF NAME Recorded Dec 18, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029488/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2012
From: TATALOVICH, JOE; THORSON, SARA; MIEZWA, MEGAN; ZAVER, STEVE; KUSLEIKA, RICH; NOFFKE, PAUL
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 027643/0111 →
Continuity (1)
Related Publication 20130204344A1 · Aug 8, 2013
Cited By (9)
US 1,077,996 US 12,232,838 US 12,263,103 US 12,343,479 US 12,376,928 US 12,453,564 US 12,558,175 US 12,702,509 US 12,714,558